High expression levels of SLC7A11 can significantly reduce the tumor growth inhibitory activity induced by p53(3KR), indicating that this inhibitory activity has nothing to do with the disturbance of cell cycle, cell apoptosis, and cell senescence. This evidence concerns the gene TP53 and neoplasm.